Navigation Links
Schizophrenics On Medication At An Increased Risk For Developing Diabetes

A recent study shows , schizophrenics treated with clozapine and olanzapine may be at an increased risk for developing type 2 diabetes. Patients taking these antipsychotic agents resisted insulin // and had impairment of glucose effectiveness compared with patients taking another drug under study.

Researchers evaluated 36 non-obese people with schizophrenia or schizoaffective disorder who were treated with clozapine (Clozaril), olanzapine (Zyprexa, Zydis), or risperidone (Risperdal). The participants followed a certain diet to maintain body weight and fasted before having a glucose tolerance test. Schizophrenics were found to have a much shorter life expectancy than the general population attributable to many factors, including cardiovascular disease.

Thus researchers conclude, that psychiatrists and primary care professionals should be aware that patients treated with clozapine and olanzapine may be at increased risk for insulin resistance, even if not obese and patients treated with these agents should be routinely screened and counseled to reduce risk, and provided early interventions.
'"/>




Page: 1

Related medicine news :

1. Music therapy for Schizophrenics
2. Schizophrenics At Greater Risk Of Developing Chronic Diseases
3. Sway Schizophrenics With Incentives to Avail Regular Treatment
4. What happens when Medications go wrong?
5. Medications to Prevent Relapse to Cocaine Use
6. More Elderly Take Inappropriate and Harmful Medications
7. Medications for depression
8. Medications linked to xerostomia and caries
9. Medication recuperates fat distribution in diabetes
10. Pharmacist’s Role in Medication Error
11. The Downside of Asthma Medication
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/23/2017)... ... , ... PKF O’Connor Davies , LLP, the nation’s 26th largest accounting ... Firm, will participate in the 40th Annual "Empire State Building Run Up" on Feb. ... steps, a vertical distance equal to about a fifth of a mile, to reach ...
(Date:1/23/2017)... ... ... plastic balance boards have been around since at least the 1950s and are a great ... and only balance board to use a patent-pending design featuring high-pressure inflation technology and drop-stitch ... well as skill-level adjustable for all ages and abilities. The board can be rolled ...
(Date:1/23/2017)... , ... January 23, 2017 , ... ... on Crystallization in Process Chemistry by Applying Simple PAT Tools . , ... compounds to isolate and purify the desired product. Chemists now spend more ...
(Date:1/23/2017)... ... January 23, 2017 , ... The ... of Anesthesiologists® (ASA®), the Foundation for Anesthesia Education and Research (FAER), the ... and the Cigna Foundation, encourages proposals supporting high quality research using perioperative ...
(Date:1/23/2017)... ... , ... “Life Under Blankets”: an entrancing story about one woman's travels ... is the creation of published author, Kimberly Mitchell, who earned her bachelor’s degree in ... to pursue a master’s degree in education in the field of curriculum and instruction. ...
Breaking Medicine News(10 mins):
(Date:1/23/2017)... 2017 Endo International plc (NASDAQ / TSX: ... filed a joint motion in the U.S. District Court ... seeking the entry of a ten-year Stipulated Order ... between the FTC and Endo relating to the patent ... Opana® ER and Lidoderm® products.  It also resolves the ...
(Date:1/23/2017)... , Jan. 23, 2017 MouthWatch LLC announced today ... was ranked as the best intraoral camera on DentalCompare,s list ... #2 spot overall. The #1 product was the CollaPlug ... MouthWatch intraoral camera was "…incredibly popular because it is by ... has a small sticker price, it doesn,t sacrifice quality imaging." ...
(Date:1/23/2017)...  Allergan plc, (NYSE: AGN ), a leading ... International Headache Academy (IHA). Designed to inspire a long-term commitment ... offers a three-day, intensive overview on research and treatment options. ... sole sponsor since the inception of IHA in ... Europe in 2014. "Allergan ...
Breaking Medicine Technology: